Skip to Main content Skip to Navigation
Journal articles

Lung cancer screening: Current status and perspective

Abstract : Lung cancer screening by low-dose computed tomography (CT) has been proven to reduce lung cancer-related mortality by 20%, in the National Lung cancer Screening Trial (NLST). Low-dose CT acquisition protocols should result in effective dose not exceeding 1.5mSv, and should be read by radiologists who have an expertise in the field. A volumetry-based approach similar to that used in the NELSON study allows reducing the rate of positive screens around 2%. The major harm of screening is overdiagnosis, which correspond to the detection of indolent tumours that would not cause the subject death. Ongoing research for the development of useful biomarkers to be combined to imaging could improve the accuracy of lung cancer screening.
Complete list of metadata
Contributor : Guillaume CHASSAGNON Connect in order to contact the contributor
Submitted on : Wednesday, December 14, 2016 - 5:53:20 PM
Last modification on : Wednesday, May 26, 2021 - 7:56:02 PM

Links full text




G. Chassagnon, M.-P. Revel. Lung cancer screening: Current status and perspective. Diagnostic and Interventional Imaging, Elsevier, 2016, 97 (10), pp.949 - 953. ⟨10.1016/j.diii.2016.06.018⟩. ⟨hal-01416745⟩



Record views